Wednesday, April 16, 2025 8:16:55 AM
I know, I know. Just like the old arguments that Elite would go bankrupt, never launch another product after Lodrane, never be profitable, never cash flow, on and on. We've now arrived at "The company's buyout won't be big enough!" LOL. Dang, I guess I'll just have to spend all my early retirement years harping about it and dry my tears with my millions.
"He's gonna RS the stock and protect himself with his preferred shares!" Never happened, he converted to common.
"He's gonna do a hostile takeover of Elite himself while the stock price is low!" Never happened. If he didn't do it at 2 and a half cents, he isn't doing it at .40+ cents.
"He stands to gain so much more from Mikah..." So..... the ultimate diabolical design is to connive his way into a few million in Mikah profits? That's the grand prize? You DO know how much 200-300+ million shares equates to in USD if the company is purchased for a couple billion dollars... right? Mikah money becomes a rounding error.
Sorry counselor, the arguments are still unpersuasive. I do think full Adderall rights ultimately land back at Elite and the warrants get exercised.
"He's gonna RS the stock and protect himself with his preferred shares!" Never happened, he converted to common.
"He's gonna do a hostile takeover of Elite himself while the stock price is low!" Never happened. If he didn't do it at 2 and a half cents, he isn't doing it at .40+ cents.
"He stands to gain so much more from Mikah..." So..... the ultimate diabolical design is to connive his way into a few million in Mikah profits? That's the grand prize? You DO know how much 200-300+ million shares equates to in USD if the company is purchased for a couple billion dollars... right? Mikah money becomes a rounding error.
Sorry counselor, the arguments are still unpersuasive. I do think full Adderall rights ultimately land back at Elite and the warrants get exercised.
Recent ELTP News
- Form 8-K - Current report • Edgar (US Regulatory) • 04/02/2026 12:05:23 PM
- Elite Pharmaceuticals Announces Commercial Launch of Methadone Hydrochloride Tablets • Newsfile • 04/02/2026 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/17/2026 10:10:32 PM
- Elite Pharmaceuticals, Inc. Reports Financial Results for the Third Quarter of Fiscal Year 2026 (three months ended December 31, 2025) and Provides Conference Call Information • Newsfile • 02/17/2026 09:19:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/17/2026 09:06:15 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/11/2026 09:35:26 PM
- Elite Pharmaceuticals, Inc. to Host Conference Call to Provide Corporate Update and Discuss Third Quarter 2026 Financial Results on February 18, 2026 • Newsfile • 02/11/2026 09:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/13/2026 09:35:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/14/2025 10:10:23 PM
- Elite Pharmaceuticals, Inc. Reports Financial Results for the Second Quarter of Fiscal Year 2026 Ended September 30, 2025 and Provides Conference Call Information • Newsfile • 11/14/2025 09:19:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:11:38 PM
- Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 11/12/2025 10:19:32 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/12/2025 12:15:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/10/2025 12:15:46 PM
- Elite Pharmaceuticals, Inc. to Host Conference Call to Provide Corporate Update and Discuss Second Quarter 2026 Financial Results on November 17, 2025 • Newsfile • 11/10/2025 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/26/2025 09:17:39 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 08/22/2025 01:39:01 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/14/2025 08:37:09 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/08/2025 08:35:45 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/25/2025 10:05:07 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/10/2025 08:17:22 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/08/2025 08:15:11 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 07/08/2025 02:58:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/30/2025 08:27:51 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 06/30/2025 08:05:59 PM
